{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:15:05Z","timestamp":1760267705333},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1007\/s00262-003-0376-9","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:07:02Z","timestamp":1576102022000},"page":"367-377","source":"Crossref","is-referenced-by-count":7,"title":["A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells"],"prefix":"10.1007","volume":"52","author":[{"given":"Pamela","family":"Krueger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Nitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren","family":"Gelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guita","family":"Lalehzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Goodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cohava","family":"Gelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,4,1]]},"reference":[{"key":"0376_CR1","first-page":"676","volume":"51","author":"Beaumier","year":"1991","unstructured":"Beaumier PL, Venkatesan P, Vanderheyden JL, Burgua WD, Kunz LL, Fritzberg,AR, AbramsPG, Morgan AC (1991)186Re radiommunotherapy of small cell lung carcinoma xenografts in nude mice. Cancer Res 51:676","journal-title":"Cancer Res"},{"key":"0376_CR2","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/1097-0142(197812)42:6<2880::AID-CNCR2820420650>3.0.CO;2-X","volume":"42","author":"Brigham","year":"1978","unstructured":"Brigham BA, Bunn PA, Minna JD, Cohen MH, Ihde DC, Shackney SE (1978) Growth rates of small cell bronchogenic carcinomas. Cancer 42:2880","journal-title":"Cancer"},{"key":"0376_CR3","first-page":"2192","volume":"45","author":"de","year":"1985","unstructured":"de Leij L, Poppema S, Nulend JK, ter Haar A, Schwander E, Ebbens F, Postmus PE, The TH (1985) Neuroendocrine differentiation antigen of human lung carcinoma and Kulchitski cells. Cancer Res 45:2192","journal-title":"Cancer Res"},{"key":"0376_CR4","unstructured":"Embleton MJ, Garnett MC (1985) Antibody targeting of anti-cancer agents: In: Baldwin RW, Byer VS (eds) Monoclonal antibodies for cancer detection and therapy. Academic Press, New York, p 317"},{"key":"0376_CR5","first-page":"261","volume":"13","author":"Gazdar","year":"1994","unstructured":"Gazdar AF (1994) The molecular and cellular basis of human lung cancer. Anticancer Res 13:261","journal-title":"Anticancer Res"},{"key":"0376_CR6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ijc.2910540521","volume":"54","author":"Heike","year":"1993","unstructured":"Heike Y, Sone S, Yano S, Seimiya H, Tsuruo T, Ogura T (1993) M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity. Int J Cancer 54:851","journal-title":"Int J Cancer"},{"key":"0376_CR7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01741331","volume":"32","author":"Hekman","year":"1991","unstructured":"Hekman A, Honselaar A Vuist W, et al. (1991) Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody. Cancer Immunol Immunother 32:364","journal-title":"Cancer Immunol Immunother"},{"key":"0376_CR8","first-page":"296","volume":"35","author":"Hosono","year":"1994","unstructured":"Hosono M, Endo K, Hososno MN, Kobayashi H, Sakahra H, Ryuzo U, Kunishi J (1994) Treatment of small cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecules monoclonal antibody and evaluation of adsorbed dose in tissue. J Nucl Med 35:296","journal-title":"J Nucl Med"},{"key":"0376_CR9","first-page":"5264","volume":"52","author":"Jackson","year":"1992","unstructured":"Jackson D, Waibel R, Weber E, Bell J, Stahel RA (1992) CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res 52:5264","journal-title":"Cancer Res"},{"key":"0376_CR10","unstructured":"Jurcic JG, Scheinberg DA, Houghton A (1996) Monoclonal antibody therapy of cancer: In: Pinedo HM, Chabner BA, Longo DL (eds) Cancer chemotherapy and biological response modifiers, Annual 16. Elsevier Science, New York, p 168"},{"key":"0376_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"K\u00c3\u00b6hler","year":"1975","unstructured":"K\u00f6hler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495","journal-title":"Nature"},{"key":"0376_CR12","unstructured":"Kwak LW, Grossbard ML, Urba WJ (1995) Clinical applications of monoclonal antibodies in cancer: In: DeVita Jr VT, Hellman S, Rosenberg SA (eds) Biologic therapy of cancer, 2nd edn. Lippincott, Philadelphia, p 553"},{"key":"0376_CR13","first-page":"255","volume":"14","author":"Livingston","year":"1994","unstructured":"Livingston RB (1994) Small cell lung cancer: from the laboratory to the clinic. Anticancer Res 14:255","journal-title":"Anticancer Res"},{"key":"0376_CR14","first-page":"2638","volume":"3","author":"Livingston","year":"1997","unstructured":"Livingston RB (1997) Combined modality therapy of lung cancer. Clin Cancer Res 3:2638","journal-title":"Clin Cancer Res"},{"key":"0376_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(81)90475-X","volume":"II","author":"Miller","year":"1981","unstructured":"Miller RA, Levy R (1981) Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet II:226","journal-title":"Lancet"},{"key":"0376_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/bjc.1994.47","volume":"69","author":"Olabiran","year":"1994","unstructured":"Olabiran Y, Ledermann JA, Martson NJ, Boxer GM, Souhami RL, Spiro SG, Stahel RA (1994) The selection of antibodies targeted therapy of small cell lung cancer (SCLC) using a human tumor spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies. Br J Cancer 69:247","journal-title":"Br J Cancer"},{"key":"0376_CR17","first-page":"263","volume":"64","author":"Smith","year":"1991","unstructured":"Smith A, Waibel R, Stahel RA (1991) Adoptive immunotherapy of small cell cancer xenografts using131I-labeled SWA11 antibody. Oncology 64:263","journal-title":"Oncology"},{"key":"0376_CR18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jnci\/83.9.609","volume":"83","author":"Souhami","year":"1991","unstructured":"Souhami RL, Beverley PCL, Bobrow LG, Ledermann JA (1991) Antigens of lung cancer: results of the second international workshop on lung cancer antigens. J Natl Cancer Inst 83:609","journal-title":"J Natl Cancer Inst"},{"key":"0376_CR19","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1378\/chest.96.1_Supplement.27S","volume":"96","author":"Stahel","year":"1989","unstructured":"Stahel RA (1989) Monoclonal antibodies to lung cancer. Chest 96:27S","journal-title":"Chest"},{"key":"0376_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0169-5002(89)90156-6","volume":"5","author":"Stahel","year":"1989","unstructured":"Stahel RA, Ginsburg R, Haveman K, et al. (1989) Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 5:119","journal-title":"Lung Cancer"},{"key":"0376_CR21","first-page":"4770","volume":"46","author":"Takahashi","year":"1986","unstructured":"Takahashi T, Ueda R, Song X, Nishida K, Shinzato M, Namikawa R, Ariyoshi Y, Ota K, Kato K, Nagatsu T (1986) Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Cancer Res 46:4770","journal-title":"Cancer Res"},{"key":"0376_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/annonc\/5.suppl_1.S13","volume":"5","author":"Waldman","year":"1994","unstructured":"Waldman TA (1994) Lymphokine receptors: a target for immunotherapy of lymphomas. Ann Oncol 5:13","journal-title":"Ann Oncol"},{"key":"0376_CR23","first-page":"826","volume":"47","author":"Watanabe","year":"1987","unstructured":"Watanabe J, Okaba T, Fujiasawa T, Takaku F, Hirohashi S, Shimosato Y (1987) Monoclonal antibody that distinguishes small cell lung cancer from non-small cell lung cancer. Cancer Res 47:826","journal-title":"Cancer Res"},{"key":"0376_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0025-7125(05)70427-2","volume":"80","author":"Wolpaw","year":"1996","unstructured":"Wolpaw DR (1996) Early detection in lung cancer. Case findings and screening. Med Clin North Am 80:63","journal-title":"Med Clin North Am"},{"key":"0376_CR25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/02841869309096145","volume":"32","author":"Zeuthen","year":"1993","unstructured":"Zeuthen J, Vangsted AJ (1993) Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer\u2014the ganglioside antigen fucosyl-GM1. Acta Oncol 32:845","journal-title":"Acta Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-003-0376-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-003-0376-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-003-0376-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:07:12Z","timestamp":1576102032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-003-0376-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["0376"],"URL":"https:\/\/doi.org\/10.1007\/s00262-003-0376-9","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,1]]}}}